Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Intervalo de año de publicación
1.
Int J Mol Med ; 47(1): 302-314, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-33416112

RESUMEN

Cerebral ischemia­reperfusion injury (CIRI), caused by the reperfusion of blocked vessels following ischemic stroke, can lead to secondary brain injury. Throughout CIRI, apoptosis serves an important role. Astragaloside IV is a potential neuroprotectant that alleviates CIRI by inhibiting apoptosis. The calcium­sensing receptor (CaSR) is a G­protein­coupled receptor, the activation of which aggravates ischemia­reperfusion injury. The aim of the present study was to investigate whether the protective effect of Astragaloside IV on CIRI may be associated with the regulation of CaSR. A rat middle cerebral artery occlusion/reperfusion (MCAO/R) model and an oxygen and glucose deprivation/reoxygenation (OGD/R) model of pheochromocytoma (PC12) cells were used to study the neuronal injury induced by CIRI. Neurological function scores (NFS), 2,3,5­triphe­nylterazolium chloride and hematoxylin and eosin staining were used to determine brain damage in rats. Cell viability was measured to evaluate the injury of OGD/R PC12 cells. Western blotting was used to examine the expression of proteins associated with apoptosis and CaSR. The CaSR antagonist NPS­2143 and agonist GdCl3 were used to further confirm the effects of CaSR during the process of apoptosis. The results demonstrated that Astragaloside IV alleviated CIRI by decreasing the NFS of rats, reducing the infarction volume of the brain and promoting the viability of PC12 cells, as well as inhibiting the expression of cleaved caspase­3 and CaSR, which was induced by CIRI. The results of the present study suggested that the activation of CaSR may be involved in CIRI­induced brain damage in rats, and that Astragaloside IV may alleviate CIRI by inhibiting CaSR activation­induced apoptosis.


Asunto(s)
Apoptosis/efectos de los fármacos , Trastornos Cerebrovasculares/metabolismo , Receptores Sensibles al Calcio/antagonistas & inhibidores , Daño por Reperfusión/metabolismo , Saponinas/farmacología , Triterpenos/farmacología , Animales , Trastornos Cerebrovasculares/tratamiento farmacológico , Trastornos Cerebrovasculares/patología , Modelos Animales de Enfermedad , Masculino , Ratas , Ratas Sprague-Dawley , Receptores Sensibles al Calcio/metabolismo , Daño por Reperfusión/tratamiento farmacológico , Daño por Reperfusión/patología
2.
Food Funct ; 5(3): 605-11, 2014 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-24504493

RESUMEN

Oxidative stress has been proven to be involved in cisplatin (DDP)-induced toxicity. The aim of the present study was to investigate a possible protective role of grape seed proanthocyanidin extract (GSPE) in DDP-induced spermiotoxicity. GSPE at 200 mg kg(-1) d(-1) and 400 mg kg(-1) d(-1) was orally administered for 15 consecutive days, starting 10 days before a single intraperitoneal dose of DDP (7 mg kg(-1)). Results revealed that testicular and epididymal weight, epididymal sperm count, motility and morphology, the activities of GSH-Px and SOD, and GSH levels were significantly decreased whereas the level of MDA was significantly increased in the DDP group rats. GSPE treatment significantly attenuated the harmful effects of DDP-induced lipid peroxidation, oxidative stress, loss of genital organ weight, as well as function of reproductive organs. These changes were restored to near normal levels by GSPE at 400 mg kg(-1) d(-1). In conclusion, GSPE has dose dependent protective effects against DDP-induced rat testicular toxicity.


Asunto(s)
Antineoplásicos/toxicidad , Cisplatino/toxicidad , Extracto de Semillas de Uva/administración & dosificación , Proantocianidinas/administración & dosificación , Testículo/efectos de los fármacos , Testículo/metabolismo , Animales , Glutatión/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Masculino , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Sprague-Dawley , Recuento de Espermatozoides , Motilidad Espermática/efectos de los fármacos , Testículo/citología
3.
Toxicol Mech Methods ; 23(6): 383-8, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23343350

RESUMEN

The aim of this study was to investigate the effects of vitamin C on cisplatin (DDP)-induced anemia and explore its possible mechanisms in rats. Adult male Sprague-Dawley rats were randomly divided into six groups: control, vitamin C 50, vitamin C 100, DDP, DDP plus vitamin C 50 and DDP plus vitamin C 100-treated groups. DDP was intravenous injected as a single dose and vitamin C was administered by gavage. Serum erythropoietin (Epo), hemoglobin (Hb) and blood urea nitrogen (BUN) concentration were measured 4 and 14 days after DDP treatment. The changes of renal tissue were examined by light microscope. Administration of DDP to rats induced anemia and nephrotoxicity, characterized with a significant decrease in serum Epo and Hb and increase in BUN concentrations. Pathological examination revealed that DDP caused significant renal damage in rats. Vitamin C administration produced amelioration in biochemical indices of anemia and nephrotoxicity and in histological change when compared to group DDP alone; concurrent administration of vitamin C at doses of 100 mg/kg being more effective. Results from this study indicate that the novel natural antioxidant vitamin C might have protective effect against DDP-induced anemia in rats.


Asunto(s)
Anemia/prevención & control , Antineoplásicos/efectos adversos , Antioxidantes/uso terapéutico , Ácido Ascórbico/uso terapéutico , Cisplatino/efectos adversos , Anemia/sangre , Anemia/inducido químicamente , Animales , Antioxidantes/administración & dosificación , Ácido Ascórbico/administración & dosificación , Relación Dosis-Respuesta a Droga , Riñón/efectos de los fármacos , Riñón/patología , Masculino , Ratas , Ratas Sprague-Dawley
4.
Chinese Journal of Burns ; (6): 93-96, 2008.
Artículo en Chino | WPRIM (Pacífico Occidental) | ID: wpr-347634

RESUMEN

<p><b>OBJECTIVE</b>To evaluate the antibacterial activity of Ciprofloxacin, Amikacin in combination with beta-lactams against Pseudomonas aeruginosa strains in vitro, to optimize treatment regime for antibiotics on the basis of pharmacokinetics (PK)/pharmacodynamics (PD) and drug sensitivity tests. Methods With checkerboard titration method, the minimal inhibitory concentrations (MIC) of a combination of antibiotics in different concentrations for 33 clinically isolated Pseudomonas aeruginosa strains were determined by broth dilution. Fractional inhibitory concentrations (FIC) were calculated for judging synergic effect of antibiotics.</p><p><b>RESULTS</b>The combination of Amikacin and Ceftazidime showed synergic effects (accounting for 57.6%). The combinations of Ciprofloxacin with Ceftazidime, Cefepime, Imipenem/Cilastatin, Meropenem showed synergic or additive effect. In the study with PK/PD, C(max)/MIC was the principal parameters for evaluation of aminoglycoside and fluoroquinolone antibiotics, while T > MIC was the principal parameter to be used to evaluate beta-lactams antibiotics.</p><p><b>CONCLUSION</b>When antibiotics are used in combination, MICs can be reduced significantly and antibacterial activities are enhanced remarkably. The combination of antibiotics results mainly in synergic or additive effect, and no inhibitory effect is observed. PK/PD analysis plays an important role in planning optimal combination regime to raise clinical efficacy.</p>


Asunto(s)
Humanos , Amicacina , Farmacocinética , Farmacología , Antibacterianos , Farmacocinética , Farmacología , Unidades de Quemados , Ciprofloxacina , Farmacocinética , Farmacología , Quimioterapia Combinada , Unidades de Cuidados Intensivos , Pruebas de Sensibilidad Microbiana , Pseudomonas aeruginosa , beta-Lactamas , Farmacocinética , Farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA